NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence?
Identifieur interne : 004C99 ( Ncbi/Curation ); précédent : 004C98; suivant : 004D00NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence?
Auteurs : Silvia Sorce [Suisse] ; Roland Stocker [Australie] ; Tamara Seredenina [Suisse] ; Rikard Holmdahl [Suède] ; Adriano Aguzzi [Suisse] ; Adriano Chio [Italie] ; Antoine Depaulis [France] ; Freddy Heitz [Suisse] ; Peter Olofsson [Suède] ; Tomas Olsson [Suède] ; Venceslas Duveau [France] ; Despina Sanoudou [Grèce] ; Sara Skosgater [France] ; Antonia Vlahou [Grèce] ; Dominique Wasquel [France] ; Karl-Heinz Krause [Suisse] ; Vincent Jaquet [Suisse]Source :
- Free radical biology & medicine [ 1873-4596 ] ; 2017.
Abstract
Neurodegenerative disease are frequently characterized by microglia activation and/or leukocyte infiltration in the parenchyma of the central nervous system and at the molecular level by increased oxidative modifications of proteins, lipids and nucleic acids. NADPH oxidases (NOX) emerged as a novel promising class of pharmacological targets for the treatment of neurodegeneration due to their role in oxidant generation and presumably in regulating microglia activation. The unique function of NOX is the generation of superoxide anion (O2(•-)) and hydrogen peroxide (H2O2). However in the context of neuroinflammation, they present paradoxical features since O2(•-)/H2O2 generated by NOX and/or secondary reactive oxygen species (ROS) derived from O2(•-)/H2O2 can either lead to neuronal oxidative damage or resolution of inflammation. The role of NOX enzymes has been investigated in many models of neurodegenerative diseases by using either genetic or pharmacological approaches. In the present review we provide a critical assessment of recent findings related to the role of NOX in the CNS as well as how the field has advanced over the last 5 years. In particular, we focus on the data derived from the work of a consortium (Neurinox) funded by the European Commission's Programme 7 (FP7). We discuss the evidence gathered from animal models and human samples linking NOX expression/activity with neuroinflammation in neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and Creutzfeldt-Jakob disease as well as autoimmune demyelinating diseases like multiple sclerosis (MS) and chronic inflammatory demyelinating polyneuropathy (CIDP). We address the possibility to use measurement of the activity of the NOX2 isoform in blood samples as biomarker of disease severity and treatment efficacy in neurodegenerative disease. Finally we clarify key controversial aspects in the field of NOX, such as NOX cellular expression in the brain, measurement of NOX activity, impact of genetic deletion of NOX in animal models of neurodegeneration and specificity of NOX inhibitors.
DOI: 10.1016/j.freeradbiomed.2017.08.006
PubMed: 28811143
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000087
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000087
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000087
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :004C99
Links to Exploration step
pubmed:28811143Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence?</title>
<author><name sortKey="Sorce, Silvia" sort="Sorce, Silvia" uniqKey="Sorce S" first="Silvia" last="Sorce">Silvia Sorce</name>
<affiliation wicri:level="4"><nlm:affiliation>Neuropathology Institute, University of Zürich, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Neuropathology Institute, University of Zürich</wicri:regionArea>
<placeName><settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
<orgName type="university">Université de Zurich</orgName>
</affiliation>
</author>
<author><name sortKey="Stocker, Roland" sort="Stocker, Roland" uniqKey="Stocker R" first="Roland" last="Stocker">Roland Stocker</name>
<affiliation wicri:level="1"><nlm:affiliation>Victor Chang Cardiac Research Institute, and School of Medical Sciences, University of New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Victor Chang Cardiac Research Institute, and School of Medical Sciences, University of New South Wales</wicri:regionArea>
<wicri:noRegion>University of New South Wales</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Seredenina, Tamara" sort="Seredenina, Tamara" uniqKey="Seredenina T" first="Tamara" last="Seredenina">Tamara Seredenina</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Pathology and Immunology, Faculty of Medicine, University of Geneva</wicri:regionArea>
<placeName><settlement type="city">Genève</settlement>
<region nuts="3" type="region">Canton de Genève</region>
</placeName>
<orgName type="university">Université de Genève</orgName>
</affiliation>
</author>
<author><name sortKey="Holmdahl, Rikard" sort="Holmdahl, Rikard" uniqKey="Holmdahl R" first="Rikard" last="Holmdahl">Rikard Holmdahl</name>
<affiliation wicri:level="1"><nlm:affiliation>Section for Medical Inflammation research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Section for Medical Inflammation research, Department of Medical Biochemistry and Biophysics, Karolinska Institute</wicri:regionArea>
<wicri:noRegion>Karolinska Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Aguzzi, Adriano" sort="Aguzzi, Adriano" uniqKey="Aguzzi A" first="Adriano" last="Aguzzi">Adriano Aguzzi</name>
<affiliation wicri:level="4"><nlm:affiliation>Neuropathology Institute, University of Zürich, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Neuropathology Institute, University of Zürich</wicri:regionArea>
<placeName><settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
<orgName type="university">Université de Zurich</orgName>
</affiliation>
</author>
<author><name sortKey="Chio, Adriano" sort="Chio, Adriano" uniqKey="Chio A" first="Adriano" last="Chio">Adriano Chio</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neuroscience, University of Torino, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino</wicri:regionArea>
<wicri:noRegion>University of Torino</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Depaulis, Antoine" sort="Depaulis, Antoine" uniqKey="Depaulis A" first="Antoine" last="Depaulis">Antoine Depaulis</name>
<affiliation wicri:level="1"><nlm:affiliation>Grenoble Institut des Neurosciences, Inserm U1216 and Univ, Grenoble Alpes, F-38000 Grenoble, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Grenoble Institut des Neurosciences, Inserm U1216 and Univ, Grenoble Alpes, F-38000 Grenoble</wicri:regionArea>
<wicri:noRegion>38000 Grenoble</wicri:noRegion>
<wicri:noRegion>38000 Grenoble</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Heitz, Freddy" sort="Heitz, Freddy" uniqKey="Heitz F" first="Freddy" last="Heitz">Freddy Heitz</name>
<affiliation wicri:level="1"><nlm:affiliation>Genkyotex SA, Plan-les-Ouates, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Genkyotex SA, Plan-les-Ouates</wicri:regionArea>
<wicri:noRegion>Plan-les-Ouates</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Olofsson, Peter" sort="Olofsson, Peter" uniqKey="Olofsson P" first="Peter" last="Olofsson">Peter Olofsson</name>
<affiliation wicri:level="1"><nlm:affiliation>Redoxis AB, Medicon Village, Lund, Sweden; Pronoxis AB, Medicon Village, Lund, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Redoxis AB, Medicon Village, Lund, Sweden; Pronoxis AB, Medicon Village, Lund</wicri:regionArea>
<wicri:noRegion>Lund</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Olsson, Tomas" sort="Olsson, Tomas" uniqKey="Olsson T" first="Tomas" last="Olsson">Tomas Olsson</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Biochemistry and Biophysics, Karolinska Institute, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Medical Biochemistry and Biophysics, Karolinska Institute</wicri:regionArea>
<wicri:noRegion>Karolinska Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Duveau, Venceslas" sort="Duveau, Venceslas" uniqKey="Duveau V" first="Venceslas" last="Duveau">Venceslas Duveau</name>
<affiliation wicri:level="1"><nlm:affiliation>SynapCell SAS, La Tronche, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>SynapCell SAS, La Tronche</wicri:regionArea>
<wicri:noRegion>La Tronche</wicri:noRegion>
<wicri:noRegion>La Tronche</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sanoudou, Despina" sort="Sanoudou, Despina" uniqKey="Sanoudou D" first="Despina" last="Sanoudou">Despina Sanoudou</name>
<affiliation wicri:level="3"><nlm:affiliation>Clinical Genomics and Pharmacogenomics Unit, 4th Department of Internal Medicine, Attikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Clinical Genomics and Pharmacogenomics Unit, 4th Department of Internal Medicine, Attikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens</wicri:regionArea>
<placeName><settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Skosgater, Sara" sort="Skosgater, Sara" uniqKey="Skosgater S" first="Sara" last="Skosgater">Sara Skosgater</name>
<affiliation wicri:level="3"><nlm:affiliation>Arttic, 58A rue du Dessous des Berges, F-75013 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Arttic, 58A rue du Dessous des Berges, F-75013 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vlahou, Antonia" sort="Vlahou, Antonia" uniqKey="Vlahou A" first="Antonia" last="Vlahou">Antonia Vlahou</name>
<affiliation wicri:level="3"><nlm:affiliation>Biomedical Research Foundation, Academy of Athens, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Biomedical Research Foundation, Academy of Athens, Athens</wicri:regionArea>
<placeName><settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wasquel, Dominique" sort="Wasquel, Dominique" uniqKey="Wasquel D" first="Dominique" last="Wasquel">Dominique Wasquel</name>
<affiliation wicri:level="3"><nlm:affiliation>Arttic, 58A rue du Dessous des Berges, F-75013 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Arttic, 58A rue du Dessous des Berges, F-75013 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Krause, Karl Heinz" sort="Krause, Karl Heinz" uniqKey="Krause K" first="Karl-Heinz" last="Krause">Karl-Heinz Krause</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Pathology and Immunology, Faculty of Medicine, University of Geneva</wicri:regionArea>
<placeName><settlement type="city">Genève</settlement>
<region nuts="3" type="region">Canton de Genève</region>
</placeName>
<orgName type="university">Université de Genève</orgName>
</affiliation>
</author>
<author><name sortKey="Jaquet, Vincent" sort="Jaquet, Vincent" uniqKey="Jaquet V" first="Vincent" last="Jaquet">Vincent Jaquet</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Switzerland. Electronic address: Vincent.Jaquet@unige.ch.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Pathology and Immunology, Faculty of Medicine, University of Geneva</wicri:regionArea>
<placeName><settlement type="city">Genève</settlement>
<region nuts="3" type="region">Canton de Genève</region>
</placeName>
<orgName type="university">Université de Genève</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28811143</idno>
<idno type="pmid">28811143</idno>
<idno type="doi">10.1016/j.freeradbiomed.2017.08.006</idno>
<idno type="wicri:Area/PubMed/Corpus">000087</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000087</idno>
<idno type="wicri:Area/PubMed/Curation">000087</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000087</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000087</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000087</idno>
<idno type="wicri:Area/Ncbi/Merge">004C99</idno>
<idno type="wicri:Area/Ncbi/Curation">004C99</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence?</title>
<author><name sortKey="Sorce, Silvia" sort="Sorce, Silvia" uniqKey="Sorce S" first="Silvia" last="Sorce">Silvia Sorce</name>
<affiliation wicri:level="4"><nlm:affiliation>Neuropathology Institute, University of Zürich, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Neuropathology Institute, University of Zürich</wicri:regionArea>
<placeName><settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
<orgName type="university">Université de Zurich</orgName>
</affiliation>
</author>
<author><name sortKey="Stocker, Roland" sort="Stocker, Roland" uniqKey="Stocker R" first="Roland" last="Stocker">Roland Stocker</name>
<affiliation wicri:level="1"><nlm:affiliation>Victor Chang Cardiac Research Institute, and School of Medical Sciences, University of New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Victor Chang Cardiac Research Institute, and School of Medical Sciences, University of New South Wales</wicri:regionArea>
<wicri:noRegion>University of New South Wales</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Seredenina, Tamara" sort="Seredenina, Tamara" uniqKey="Seredenina T" first="Tamara" last="Seredenina">Tamara Seredenina</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Pathology and Immunology, Faculty of Medicine, University of Geneva</wicri:regionArea>
<placeName><settlement type="city">Genève</settlement>
<region nuts="3" type="region">Canton de Genève</region>
</placeName>
<orgName type="university">Université de Genève</orgName>
</affiliation>
</author>
<author><name sortKey="Holmdahl, Rikard" sort="Holmdahl, Rikard" uniqKey="Holmdahl R" first="Rikard" last="Holmdahl">Rikard Holmdahl</name>
<affiliation wicri:level="1"><nlm:affiliation>Section for Medical Inflammation research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Section for Medical Inflammation research, Department of Medical Biochemistry and Biophysics, Karolinska Institute</wicri:regionArea>
<wicri:noRegion>Karolinska Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Aguzzi, Adriano" sort="Aguzzi, Adriano" uniqKey="Aguzzi A" first="Adriano" last="Aguzzi">Adriano Aguzzi</name>
<affiliation wicri:level="4"><nlm:affiliation>Neuropathology Institute, University of Zürich, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Neuropathology Institute, University of Zürich</wicri:regionArea>
<placeName><settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
<orgName type="university">Université de Zurich</orgName>
</affiliation>
</author>
<author><name sortKey="Chio, Adriano" sort="Chio, Adriano" uniqKey="Chio A" first="Adriano" last="Chio">Adriano Chio</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neuroscience, University of Torino, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino</wicri:regionArea>
<wicri:noRegion>University of Torino</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Depaulis, Antoine" sort="Depaulis, Antoine" uniqKey="Depaulis A" first="Antoine" last="Depaulis">Antoine Depaulis</name>
<affiliation wicri:level="1"><nlm:affiliation>Grenoble Institut des Neurosciences, Inserm U1216 and Univ, Grenoble Alpes, F-38000 Grenoble, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Grenoble Institut des Neurosciences, Inserm U1216 and Univ, Grenoble Alpes, F-38000 Grenoble</wicri:regionArea>
<wicri:noRegion>38000 Grenoble</wicri:noRegion>
<wicri:noRegion>38000 Grenoble</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Heitz, Freddy" sort="Heitz, Freddy" uniqKey="Heitz F" first="Freddy" last="Heitz">Freddy Heitz</name>
<affiliation wicri:level="1"><nlm:affiliation>Genkyotex SA, Plan-les-Ouates, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Genkyotex SA, Plan-les-Ouates</wicri:regionArea>
<wicri:noRegion>Plan-les-Ouates</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Olofsson, Peter" sort="Olofsson, Peter" uniqKey="Olofsson P" first="Peter" last="Olofsson">Peter Olofsson</name>
<affiliation wicri:level="1"><nlm:affiliation>Redoxis AB, Medicon Village, Lund, Sweden; Pronoxis AB, Medicon Village, Lund, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Redoxis AB, Medicon Village, Lund, Sweden; Pronoxis AB, Medicon Village, Lund</wicri:regionArea>
<wicri:noRegion>Lund</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Olsson, Tomas" sort="Olsson, Tomas" uniqKey="Olsson T" first="Tomas" last="Olsson">Tomas Olsson</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Biochemistry and Biophysics, Karolinska Institute, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Medical Biochemistry and Biophysics, Karolinska Institute</wicri:regionArea>
<wicri:noRegion>Karolinska Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Duveau, Venceslas" sort="Duveau, Venceslas" uniqKey="Duveau V" first="Venceslas" last="Duveau">Venceslas Duveau</name>
<affiliation wicri:level="1"><nlm:affiliation>SynapCell SAS, La Tronche, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>SynapCell SAS, La Tronche</wicri:regionArea>
<wicri:noRegion>La Tronche</wicri:noRegion>
<wicri:noRegion>La Tronche</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sanoudou, Despina" sort="Sanoudou, Despina" uniqKey="Sanoudou D" first="Despina" last="Sanoudou">Despina Sanoudou</name>
<affiliation wicri:level="3"><nlm:affiliation>Clinical Genomics and Pharmacogenomics Unit, 4th Department of Internal Medicine, Attikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Clinical Genomics and Pharmacogenomics Unit, 4th Department of Internal Medicine, Attikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens</wicri:regionArea>
<placeName><settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Skosgater, Sara" sort="Skosgater, Sara" uniqKey="Skosgater S" first="Sara" last="Skosgater">Sara Skosgater</name>
<affiliation wicri:level="3"><nlm:affiliation>Arttic, 58A rue du Dessous des Berges, F-75013 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Arttic, 58A rue du Dessous des Berges, F-75013 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vlahou, Antonia" sort="Vlahou, Antonia" uniqKey="Vlahou A" first="Antonia" last="Vlahou">Antonia Vlahou</name>
<affiliation wicri:level="3"><nlm:affiliation>Biomedical Research Foundation, Academy of Athens, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Biomedical Research Foundation, Academy of Athens, Athens</wicri:regionArea>
<placeName><settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wasquel, Dominique" sort="Wasquel, Dominique" uniqKey="Wasquel D" first="Dominique" last="Wasquel">Dominique Wasquel</name>
<affiliation wicri:level="3"><nlm:affiliation>Arttic, 58A rue du Dessous des Berges, F-75013 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Arttic, 58A rue du Dessous des Berges, F-75013 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Krause, Karl Heinz" sort="Krause, Karl Heinz" uniqKey="Krause K" first="Karl-Heinz" last="Krause">Karl-Heinz Krause</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Pathology and Immunology, Faculty of Medicine, University of Geneva</wicri:regionArea>
<placeName><settlement type="city">Genève</settlement>
<region nuts="3" type="region">Canton de Genève</region>
</placeName>
<orgName type="university">Université de Genève</orgName>
</affiliation>
</author>
<author><name sortKey="Jaquet, Vincent" sort="Jaquet, Vincent" uniqKey="Jaquet V" first="Vincent" last="Jaquet">Vincent Jaquet</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Switzerland. Electronic address: Vincent.Jaquet@unige.ch.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Pathology and Immunology, Faculty of Medicine, University of Geneva</wicri:regionArea>
<placeName><settlement type="city">Genève</settlement>
<region nuts="3" type="region">Canton de Genève</region>
</placeName>
<orgName type="university">Université de Genève</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j">Free radical biology & medicine</title>
<idno type="eISSN">1873-4596</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Neurodegenerative disease are frequently characterized by microglia activation and/or leukocyte infiltration in the parenchyma of the central nervous system and at the molecular level by increased oxidative modifications of proteins, lipids and nucleic acids. NADPH oxidases (NOX) emerged as a novel promising class of pharmacological targets for the treatment of neurodegeneration due to their role in oxidant generation and presumably in regulating microglia activation. The unique function of NOX is the generation of superoxide anion (O2(•-)) and hydrogen peroxide (H2O2). However in the context of neuroinflammation, they present paradoxical features since O2(•-)/H2O2 generated by NOX and/or secondary reactive oxygen species (ROS) derived from O2(•-)/H2O2 can either lead to neuronal oxidative damage or resolution of inflammation. The role of NOX enzymes has been investigated in many models of neurodegenerative diseases by using either genetic or pharmacological approaches. In the present review we provide a critical assessment of recent findings related to the role of NOX in the CNS as well as how the field has advanced over the last 5 years. In particular, we focus on the data derived from the work of a consortium (Neurinox) funded by the European Commission's Programme 7 (FP7). We discuss the evidence gathered from animal models and human samples linking NOX expression/activity with neuroinflammation in neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and Creutzfeldt-Jakob disease as well as autoimmune demyelinating diseases like multiple sclerosis (MS) and chronic inflammatory demyelinating polyneuropathy (CIDP). We address the possibility to use measurement of the activity of the NOX2 isoform in blood samples as biomarker of disease severity and treatment efficacy in neurodegenerative disease. Finally we clarify key controversial aspects in the field of NOX, such as NOX cellular expression in the brain, measurement of NOX activity, impact of genetic deletion of NOX in animal models of neurodegeneration and specificity of NOX inhibitors.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004C99 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 004C99 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:28811143 |texte= NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:28811143" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |